Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015541
Filing Date
2020-06-05
Accepted
2020-06-05 20:02:15
Documents
1
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7115
  Complete submission text file 0000899243-20-015541.txt   8550
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301
Business Address
YAU YI CHING (Reporting) CIK: 0001790097 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20947858